Cargando…

Curcumin Induces Cell Death and Restores Tamoxifen Sensitivity in the Antiestrogen-Resistant Breast Cancer Cell Lines MCF-7/LCC2 and MCF-7/LCC9

Curcumin, a principal component of turmeric (Curcuma longa), has potential therapeutic activities against breast cancer through multiple signaling pathways. Increasing evidence indicates that curcumin reverses chemo-resistance and sensitizes cancer cells to chemotherapy and targeted therapy in breas...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Min, Huang, Ou, Zhang, Xi, Xie, Zuoquan, Shen, Aijun, Liu, Hongchun, Geng, Meiyu, Shen, Kunwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269686/
https://www.ncbi.nlm.nih.gov/pubmed/23299550
http://dx.doi.org/10.3390/molecules18010701
_version_ 1783376525462077440
author Jiang, Min
Huang, Ou
Zhang, Xi
Xie, Zuoquan
Shen, Aijun
Liu, Hongchun
Geng, Meiyu
Shen, Kunwei
author_facet Jiang, Min
Huang, Ou
Zhang, Xi
Xie, Zuoquan
Shen, Aijun
Liu, Hongchun
Geng, Meiyu
Shen, Kunwei
author_sort Jiang, Min
collection PubMed
description Curcumin, a principal component of turmeric (Curcuma longa), has potential therapeutic activities against breast cancer through multiple signaling pathways. Increasing evidence indicates that curcumin reverses chemo-resistance and sensitizes cancer cells to chemotherapy and targeted therapy in breast cancer. To date, few studies have explored its potential antiproliferation effects and resistance reversal in antiestrogen-resistant breast cancer. In this study, we therefore investigated the efficacy of curcumin alone and in combination with tamoxifen in the established antiestrogen-resistant breast cancer cell lines MCF-7/LCC2 and MCF-7/LCC9. We discovered that curcumin treatment displayed anti-proliferative and pro-apoptotic activities and induced cell cycle arrest at G2/M phase. Of note, the combination of curcumin and tamoxifen resulted in a synergistic survival inhibition in MCF-7/LCC2 and MCF-7/LCC9 cells. Moreover, we found that curcumin targeted multiple signals involved in growth maintenance and resistance acquisition in endocrine resistant cells. In our cell models, curcumin could suppress expression of pro-growth and anti-apoptosis molecules, induce inactivation of NF-κB, Src and Akt/mTOR pathways and downregulate the key epigenetic modifier EZH2. The above findings suggested that curcumin alone and combinations of curcumin with endocrine therapy may be of therapeutic benefit for endocrine-resistant breast cancer.
format Online
Article
Text
id pubmed-6269686
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-62696862018-12-14 Curcumin Induces Cell Death and Restores Tamoxifen Sensitivity in the Antiestrogen-Resistant Breast Cancer Cell Lines MCF-7/LCC2 and MCF-7/LCC9 Jiang, Min Huang, Ou Zhang, Xi Xie, Zuoquan Shen, Aijun Liu, Hongchun Geng, Meiyu Shen, Kunwei Molecules Article Curcumin, a principal component of turmeric (Curcuma longa), has potential therapeutic activities against breast cancer through multiple signaling pathways. Increasing evidence indicates that curcumin reverses chemo-resistance and sensitizes cancer cells to chemotherapy and targeted therapy in breast cancer. To date, few studies have explored its potential antiproliferation effects and resistance reversal in antiestrogen-resistant breast cancer. In this study, we therefore investigated the efficacy of curcumin alone and in combination with tamoxifen in the established antiestrogen-resistant breast cancer cell lines MCF-7/LCC2 and MCF-7/LCC9. We discovered that curcumin treatment displayed anti-proliferative and pro-apoptotic activities and induced cell cycle arrest at G2/M phase. Of note, the combination of curcumin and tamoxifen resulted in a synergistic survival inhibition in MCF-7/LCC2 and MCF-7/LCC9 cells. Moreover, we found that curcumin targeted multiple signals involved in growth maintenance and resistance acquisition in endocrine resistant cells. In our cell models, curcumin could suppress expression of pro-growth and anti-apoptosis molecules, induce inactivation of NF-κB, Src and Akt/mTOR pathways and downregulate the key epigenetic modifier EZH2. The above findings suggested that curcumin alone and combinations of curcumin with endocrine therapy may be of therapeutic benefit for endocrine-resistant breast cancer. MDPI 2013-01-08 /pmc/articles/PMC6269686/ /pubmed/23299550 http://dx.doi.org/10.3390/molecules18010701 Text en © 2013 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Article
Jiang, Min
Huang, Ou
Zhang, Xi
Xie, Zuoquan
Shen, Aijun
Liu, Hongchun
Geng, Meiyu
Shen, Kunwei
Curcumin Induces Cell Death and Restores Tamoxifen Sensitivity in the Antiestrogen-Resistant Breast Cancer Cell Lines MCF-7/LCC2 and MCF-7/LCC9
title Curcumin Induces Cell Death and Restores Tamoxifen Sensitivity in the Antiestrogen-Resistant Breast Cancer Cell Lines MCF-7/LCC2 and MCF-7/LCC9
title_full Curcumin Induces Cell Death and Restores Tamoxifen Sensitivity in the Antiestrogen-Resistant Breast Cancer Cell Lines MCF-7/LCC2 and MCF-7/LCC9
title_fullStr Curcumin Induces Cell Death and Restores Tamoxifen Sensitivity in the Antiestrogen-Resistant Breast Cancer Cell Lines MCF-7/LCC2 and MCF-7/LCC9
title_full_unstemmed Curcumin Induces Cell Death and Restores Tamoxifen Sensitivity in the Antiestrogen-Resistant Breast Cancer Cell Lines MCF-7/LCC2 and MCF-7/LCC9
title_short Curcumin Induces Cell Death and Restores Tamoxifen Sensitivity in the Antiestrogen-Resistant Breast Cancer Cell Lines MCF-7/LCC2 and MCF-7/LCC9
title_sort curcumin induces cell death and restores tamoxifen sensitivity in the antiestrogen-resistant breast cancer cell lines mcf-7/lcc2 and mcf-7/lcc9
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269686/
https://www.ncbi.nlm.nih.gov/pubmed/23299550
http://dx.doi.org/10.3390/molecules18010701
work_keys_str_mv AT jiangmin curcumininducescelldeathandrestorestamoxifensensitivityintheantiestrogenresistantbreastcancercelllinesmcf7lcc2andmcf7lcc9
AT huangou curcumininducescelldeathandrestorestamoxifensensitivityintheantiestrogenresistantbreastcancercelllinesmcf7lcc2andmcf7lcc9
AT zhangxi curcumininducescelldeathandrestorestamoxifensensitivityintheantiestrogenresistantbreastcancercelllinesmcf7lcc2andmcf7lcc9
AT xiezuoquan curcumininducescelldeathandrestorestamoxifensensitivityintheantiestrogenresistantbreastcancercelllinesmcf7lcc2andmcf7lcc9
AT shenaijun curcumininducescelldeathandrestorestamoxifensensitivityintheantiestrogenresistantbreastcancercelllinesmcf7lcc2andmcf7lcc9
AT liuhongchun curcumininducescelldeathandrestorestamoxifensensitivityintheantiestrogenresistantbreastcancercelllinesmcf7lcc2andmcf7lcc9
AT gengmeiyu curcumininducescelldeathandrestorestamoxifensensitivityintheantiestrogenresistantbreastcancercelllinesmcf7lcc2andmcf7lcc9
AT shenkunwei curcumininducescelldeathandrestorestamoxifensensitivityintheantiestrogenresistantbreastcancercelllinesmcf7lcc2andmcf7lcc9